Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASR | P41180 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 4/20 | 0.44 |
| ▸ | F7 | P08709 | 3/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.42 |
| ▸ | F10 | P00742 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.41 |
| ▸ | ITGAV | P06756 | 2/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | ITGB5 | P18084 | 1/20 | 0.41 |
| ▸ | ITGB6 | P18564 | 1/20 | 0.41 |
| ▸ | FPR2 | P25090 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6806161 | 0.95 | ITGAV (0.46) | CASRPOLBCTDSP1KMT2AMEN1 | |
| SCHEMBL6806187 | 0.93 | ITGAV (0.45) | CASRF7F2F10ITGB3 | |
| SCHEMBL6805508 | 0.91 | CASR (0.48) | CASRKMT2AMEN1F7F2 | |
| Trifluoroacetic Acid SCHEMBL6804033 | 0.89 | ITGB3 (0.48) | CASRPOLBCTDSP1KMT2AMEN1 | |
| SCHEMBL6806722 | 0.89 | EPHX1 (0.41) | CASRF7F2F10ITGB3 | |
| SCHEMBL6801129 | 0.88 | ITGAV (0.47) | CASRF7F2ITGB3ITGAV | |
| SCHEMBL6806430 | 0.88 | ITGAV (0.50) | CASRITGB3ITGAVITGA2BITGB5 | |
| SCHEMBL6545220 | 0.87 | CASR (0.53) | CASRPOLBCTDSP1KMT2AMEN1 | |
| SCHEMBL6806861 | 0.87 | KMT2A (0.47) | CASRKMT2AF7F2ITGB3 | |
| SCHEMBL6806865 | 0.87 | PKM (0.42) | KMT2AMEN1ITGB3ITGAVITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040142877-A1 | Ligands of the $g(a)v$g(b)6 integrin | MERCK PATENT GMBH (DE) | 2004-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040142877-A1 | Ligands of the $g(a)v$g(b)6 integrin | ITGB6, ITGAV, ITGB1 | CASR 954/4885POLB 3435/4885CTDSP1 3443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.